Chloe Teasdale

Chloe Teasdale

Assistant Professor of Epidemiology and Biostatistics

[email protected]

PhD, Epidemiology
Columbia University

MPH, Epidemiology
Columbia University

Barnard College

Chloe Teasdale is an epidemiologist who has been working in the field of HIV implementation and research for more than 15 years. She began her career at the MTCT-Plus Initiative at the Mailman School of Public Health, one of the first multi-country HIV care and treatment projects in sub-Saharan Africa and Asia, followed by continued work supporting HIV prevention and treatment scale-up with ICAP at Columbia University and with mothers2mothers, a South African public health NGO. Dr. Teasdale was previously the Deputy Director for Research at ICAP where she designed program evaluations to answer key research questions related to optimizing Global HIV program implementation. She has designed and implemented prospective cohort studies to examine outcomes among children living with HIV in South Africa and has led evaluations of innovative service delivery models, including the introduction of birth testing for HIV-exposed infants in Eswatini and an innovative group care model for pregnant adolescents living with HIV in Kenya. Dr. Teasdale is also a member of the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) of the International AIDS Society (IAS) which brings together international collaborators to conduct analyses using pooled cohort data from HIV-infected children and adolescents around the globe.

Dr. Teasdale is an Assistant Professor in the Department of Epidemiology and Biostatistics at the CUNY Graduate School of Public Health and Health Policy and Adjunct Assistant Professor in the Department of Epidemiology at the Mailman School of Public Health, Columbia University.

Dr. Teasdaleā€™s work in the area of implementation science is dedicated to improving HIV prevention, care and treatment services for women, including pregnant women, children and adolescents at risk for and living with HIV.